Loading stock data…
DH
$0.99+0.04 (+3.75%)
After Hours$0.99+0.00 (+0.00%)· Last close May 11
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Definitive Healthcare Corp. in the Healthcare sector is trading at $0.99. The stock is currently near its 52-week low of $0.90, remaining 60.3% below its 200-day moving average. Technical signals show neutral RSI of 45 and bullish MACD crossover, explaining why DH maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 45) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.99
Potential Upside
5%
Whystock Fair Value$1.04
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus8 analysts
Hold
Mean target$2.29+132.1%
Range$1.00 – $3.50
Fundamentals
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$104.45M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.60
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-49.42%
Volume
Today's trading volume
410,459
Recent News
Analysts Have Made A Financial Statement On Definitive Healthcare Corp.'s (NASDAQ:DH) First-Quarter Report
Definitive Healthcare Corp. ( NASDAQ:DH ) shareholders are probably feeling a little disappointed, since its shares...
Definitive Healthcare Q1 Earnings Call Highlights
Definitive Healthcare (NASDAQ:DH) reported first-quarter fiscal 2026 results that management said came in “at or above the high end” of guidance on both revenue and profitability, while reiterating that the company remains in a transition period as it works to return to consistent top-line growth.
Definitive Healthcare Corp. Q1 2026 Earnings Call Summary
Moby summary of Definitive Healthcare Corp.'s Q1 2026 earnings call
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
Definitive Healthcare (DH) delivered earnings and revenue surprises of +100.00% and -24.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Docebo Inc. (DCBO) Reports Next Week: Wall Street Expects Earnings Growth
Docebo (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.